Clinical Trial Update: Chidamide in Combination With PD-1 Inhibitor, Bevacizumab, and XELOX for Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating chidamide in combination with a PD-1 inhibitor, bevacizumab, and XELOX for metastatic colorectal cancer. The study status is NOT_YET_…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• Chidamide (chidamide)
• OXALIPLATIN (Oxaliplatin)
• PD-1 inhibitor

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING